MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma

Phase 1
Completed
Conditions
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Interventions
First Posted Date
2011-09-05
Last Posted Date
2019-10-08
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
26
Registration Number
NCT01429025
Locations
🇺🇸

Iowa Lutheran Hospital, Des Moines, Iowa, United States

🇺🇸

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

🇺🇸

Iowa Oncology Research Association CCOP, Des Moines, Iowa, United States

and more 14 locations

Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer

Withdrawn
Conditions
Lung Cancer
Interventions
Other: laboratory biomarker analysis
First Posted Date
2011-08-12
Last Posted Date
2019-01-24
Lead Sponsor
Alliance for Clinical Trials in Oncology
Registration Number
NCT01415739
Locations
🇺🇸

Alliance for Clinical Trials in Oncology, Boston, Massachusetts, United States

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Completed
Conditions
Lung Cancer
Interventions
Genetic: DNA analysis
Genetic: DNA methylation analysis
Genetic: RNA analysis
Genetic: gene expression analysis
Genetic: polymorphism analysis
Other: laboratory biomarker analysis
Other: medical chart review
First Posted Date
2011-08-11
Last Posted Date
2017-06-27
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
248
Registration Number
NCT01414595
Locations
🇺🇸

Union Hospital of Cecil County, Elkton, Maryland, United States

🇺🇸

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

and more 8 locations

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Phase 3
Completed
Conditions
Breast Cancer
Gynecologic Cancer
Interventions
Other: placebo
First Posted Date
2011-06-20
Last Posted Date
2019-02-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
464
Registration Number
NCT01376349
Locations
🇺🇸

St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States

🇺🇸

Illinois CancerCare - Macomb, Macomb, Illinois, United States

🇺🇸

Elkhart Clinic, LLC, Elkhart, Indiana, United States

and more 274 locations

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

Phase 3
Completed
Conditions
Metastatic Cancer
Neurotoxicity
Unspecified Adult Solid Tumor, Protocol Specific
Cognitive/Functional Effects
Radiation Toxicity
Interventions
Radiation: whole-brain radiation therapy
Radiation: stereotactic radiosurgery
First Posted Date
2011-06-14
Last Posted Date
2022-09-16
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
194
Registration Number
NCT01372774
Locations
🇺🇸

John B Amos Cancer Center, Columbus, Georgia, United States

🇺🇸

United Hospital, Saint Paul, Minnesota, United States

🇺🇸

Mount Sinai Medical Center, Miami Beach, Florida, United States

and more 34 locations

Biomarkers in Tissue Samples From Older Women With Breast Cancer

Terminated
Conditions
Breast Cancer
First Posted Date
2011-05-03
Last Posted Date
2016-07-04
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
505
Registration Number
NCT01346579

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

Phase 3
Terminated
Conditions
Lung Cancer
Interventions
Procedure: therapeutic conventional surgery
Radiation: stereotactic body radiation therapy
Radiation: iodine I 125
First Posted Date
2011-04-18
Last Posted Date
2017-05-30
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
13
Registration Number
NCT01336894
Locations
🇺🇸

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States

🇺🇸

Tufts Medical Center Cancer Center, Boston, Massachusetts, United States

🇺🇸

William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States

and more 50 locations

Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

First Posted Date
2011-04-13
Last Posted Date
2017-08-10
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
26
Registration Number
NCT01334502
Locations
🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Phase 2
Completed
Conditions
Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer
Interventions
Procedure: Positron Emission Tomography
Procedure: Computed Tomography
Radiation: Radiation Therapy
First Posted Date
2011-04-11
Last Posted Date
2023-04-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
257
Registration Number
NCT01333033
Locations
🇺🇸

Diagnostic and Treatment Center, Weston, Wisconsin, United States

🇺🇸

Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States

🇺🇸

Saint Joseph's Hospital, Marshfield, Wisconsin, United States

and more 65 locations

Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer

Completed
Conditions
Pancreatic Cancer
Interventions
Genetic: polymorphism analysis
Other: immunologic technique
Other: laboratory biomarker analysis
Other: medical chart review
First Posted Date
2011-04-04
Last Posted Date
2016-06-29
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
265
Registration Number
NCT01327794
Locations
🇺🇸

Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls, New York, United States

© Copyright 2025. All Rights Reserved by MedPath